ENTITY
SMARTSCORE: 3/5
Hugel Inc

Hugel Inc (145020 KS)

52
Analysis
Health CareSouth Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bullishHanon Systems
21 Dec 2021 22:17

Korea M&A Recap in 2021 - A Leapfrog Year

2021 has been a leapfrog year in terms of major M&As in Korea. Some of the largest M&A deals in 2022 could include Hanon Systems, Bodyfriend,...

Logo
373 Views
Share
bearishBNC Korea
29 Oct 2021 14:50

BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst

In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...

Logo
173 Views
Share
bullishEubiologics
12 Oct 2021 16:28

EuBiologics (206650 KS): Cashing on Vaccine Business

Eubiologics is on a stable growth path, driven by increasing demand of its oral cholera vaccine business. Upcoming commercialization of COVID-19...

Logo
900 Views
Share
bearishHugel Inc
14 Aug 2021 21:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
493 Views
Share
bearishHugel Inc
29 Jun 2020 10:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
410 Views
Share
x